US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 47.730
  • -1.810-3.65%
Close Oct 31 16:00 ET
2.92BMarket Cap-10972P/E (TTM)

Rhythm Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
51.28%29.08M
126.41%25.97M
227.56%77.43M
175.70%24.23M
425.30%22.5M
112.01%19.22M
665.62%11.47M
649.46%23.64M
383.76%8.79M
316.73%4.28M
Operating revenue
51.28%29.08M
126.41%25.97M
227.56%77.43M
175.70%24.23M
425.30%22.5M
112.01%19.22M
665.62%11.47M
649.46%23.64M
383.76%8.79M
316.73%4.28M
Cost of revenue
31.80%2.95M
97.54%2.81M
336.10%9.3M
214.49%3.23M
385.31%2.41M
491.53%2.24M
517.83%1.42M
256.09%2.13M
335.59%1.03M
123.87%497K
Gross profit
53.85%26.13M
130.49%23.16M
216.79%68.13M
170.56%21M
430.55%20.09M
95.50%16.99M
692.43%10.05M
741.68%21.51M
390.96%7.76M
369.85%3.79M
Operating expense
4.75%66.61M
160.55%163.05M
25.83%252.48M
24.87%62.27M
48.76%64.05M
18.23%63.59M
15.98%62.58M
16.25%200.66M
-5.15%49.87M
-4.42%43.05M
Selling and administrative expenses
21.20%36.42M
39.57%34.38M
27.71%117.53M
23.02%32.37M
38.91%30.48M
34.57%30.05M
14.85%24.63M
34.38%92.03M
25.34%26.32M
25.31%21.94M
Research and development costs
-9.98%30.19M
239.08%128.67M
24.23%134.95M
26.94%29.89M
58.98%33.57M
6.63%33.54M
16.72%37.95M
4.32%108.63M
-25.42%23.55M
-23.32%21.12M
Operating profit
13.14%-40.48M
-166.29%-139.89M
-2.90%-184.36M
1.99%-41.27M
-11.93%-43.95M
-3.34%-46.6M
0.30%-52.53M
-5.35%-179.16M
17.43%-42.1M
11.24%-39.27M
Net non-operating interest income expense
-517.07%-506K
-550.92%-1.71M
104.52%53K
-2,536.67%-731K
125.90%317K
-135.96%-82K
136.88%379K
-362.19%-1.17M
-77.61%30K
-986.96%-1.22M
Non-operating interest income
27.20%4.1M
-11.45%3.05M
246.12%13.95M
25.58%3.82M
276.74%3.47M
1,075.55%3.22M
2,050.00%3.44M
801.34%4.03M
2,169.40%3.04M
566.67%920K
Non-operating interest expense
39.36%4.6M
55.34%4.76M
167.10%13.89M
51.11%4.55M
46.88%3.15M
7,080.43%3.3M
--3.06M
--5.2M
--3.01M
--2.14M
Other net income (expense)
54,229.41%9.2M
2,040.74%524K
124.05%190K
233.10%559K
57.03%-159K
87.22%-17K
88.41%-27K
-100.79%-790K
-420K
-370K
Gain on sale of security
--8.9M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
1,876.47%302K
2,040.74%524K
124.05%190K
233.10%559K
57.03%-159K
87.22%-17K
88.41%-27K
-100.79%-790K
---420K
---370K
Income before tax
31.95%-31.78M
-170.36%-141.07M
-1.65%-184.11M
2.49%-41.44M
-7.18%-43.8M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
16.44%-42.49M
7.35%-40.86M
Income tax
479K
300K
564K
196K
368K
0
0
0
0
0
Net income
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
Net income continuous Operations
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
Minority interest income
Net income attributable to the parent company
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
Preferred stock dividends
1.3M
Other preferred stock dividends
Net income attributable to common stockholders
28.14%-33.56M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
Basic earnings per share
32.93%-0.55
-155.43%-2.35
7.78%-3.2
6.67%-0.7
3.80%-0.76
7.87%-0.82
12.38%-0.92
-147.86%-3.47
11.76%-0.75
-12.86%-0.79
Diluted earnings per share
32.93%-0.55
-155.43%-2.35
7.78%-3.2
6.67%-0.7
3.80%-0.76
7.87%-0.82
12.38%-0.92
-147.86%-3.47
11.76%-0.75
-12.86%-0.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 51.28%29.08M126.41%25.97M227.56%77.43M175.70%24.23M425.30%22.5M112.01%19.22M665.62%11.47M649.46%23.64M383.76%8.79M316.73%4.28M
Operating revenue 51.28%29.08M126.41%25.97M227.56%77.43M175.70%24.23M425.30%22.5M112.01%19.22M665.62%11.47M649.46%23.64M383.76%8.79M316.73%4.28M
Cost of revenue 31.80%2.95M97.54%2.81M336.10%9.3M214.49%3.23M385.31%2.41M491.53%2.24M517.83%1.42M256.09%2.13M335.59%1.03M123.87%497K
Gross profit 53.85%26.13M130.49%23.16M216.79%68.13M170.56%21M430.55%20.09M95.50%16.99M692.43%10.05M741.68%21.51M390.96%7.76M369.85%3.79M
Operating expense 4.75%66.61M160.55%163.05M25.83%252.48M24.87%62.27M48.76%64.05M18.23%63.59M15.98%62.58M16.25%200.66M-5.15%49.87M-4.42%43.05M
Selling and administrative expenses 21.20%36.42M39.57%34.38M27.71%117.53M23.02%32.37M38.91%30.48M34.57%30.05M14.85%24.63M34.38%92.03M25.34%26.32M25.31%21.94M
Research and development costs -9.98%30.19M239.08%128.67M24.23%134.95M26.94%29.89M58.98%33.57M6.63%33.54M16.72%37.95M4.32%108.63M-25.42%23.55M-23.32%21.12M
Operating profit 13.14%-40.48M-166.29%-139.89M-2.90%-184.36M1.99%-41.27M-11.93%-43.95M-3.34%-46.6M0.30%-52.53M-5.35%-179.16M17.43%-42.1M11.24%-39.27M
Net non-operating interest income expense -517.07%-506K-550.92%-1.71M104.52%53K-2,536.67%-731K125.90%317K-135.96%-82K136.88%379K-362.19%-1.17M-77.61%30K-986.96%-1.22M
Non-operating interest income 27.20%4.1M-11.45%3.05M246.12%13.95M25.58%3.82M276.74%3.47M1,075.55%3.22M2,050.00%3.44M801.34%4.03M2,169.40%3.04M566.67%920K
Non-operating interest expense 39.36%4.6M55.34%4.76M167.10%13.89M51.11%4.55M46.88%3.15M7,080.43%3.3M--3.06M--5.2M--3.01M--2.14M
Other net income (expense) 54,229.41%9.2M2,040.74%524K124.05%190K233.10%559K57.03%-159K87.22%-17K88.41%-27K-100.79%-790K-420K-370K
Gain on sale of security --8.9M------------------------------------
Other non- operating income (expenses) 1,876.47%302K2,040.74%524K124.05%190K233.10%559K57.03%-159K87.22%-17K88.41%-27K-100.79%-790K---420K---370K
Income before tax 31.95%-31.78M-170.36%-141.07M-1.65%-184.11M2.49%-41.44M-7.18%-43.8M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M16.44%-42.49M7.35%-40.86M
Income tax 479K300K564K196K368K00000
Net income 30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M
Net income continuous Operations 30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M
Minority interest income
Net income attributable to the parent company 30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M
Preferred stock dividends 1.3M
Other preferred stock dividends
Net income attributable to common stockholders 28.14%-33.56M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M
Basic earnings per share 32.93%-0.55-155.43%-2.357.78%-3.26.67%-0.73.80%-0.767.87%-0.8212.38%-0.92-147.86%-3.4711.76%-0.75-12.86%-0.79
Diluted earnings per share 32.93%-0.55-155.43%-2.357.78%-3.26.67%-0.73.80%-0.767.87%-0.8212.38%-0.92-147.86%-3.4711.76%-0.75-12.86%-0.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data